Arthur Peter Bertolino - Net Worth and Insider Trading

Arthur Peter Bertolino Net Worth

The estimated net worth of Arthur Peter Bertolino is at least $140,424 dollars as of 2024-11-13. Arthur Peter Bertolino is the EVP and Chief Medical Officer of Revance Therapeutics Inc and owns about 34,001 shares of Revance Therapeutics Inc (RVNC) stock worth over $140,424. Details can be seen in Arthur Peter Bertolino's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arthur Peter Bertolino has not made any transactions after 2015-11-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Arthur Peter Bertolino

To

Arthur Peter Bertolino Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arthur Peter Bertolino owns 2 companies in total, including Innovation Pharmaceuticals Inc (IPIX) , and Revance Therapeutics Inc (RVNC) .

Click here to see the complete history of Arthur Peter Bertolino’s form 4 insider trades.

Insider Ownership Summary of Arthur Peter Bertolino

Ticker Comapny Transaction Date Type of Owner
IPIX Innovation Pharmaceuticals Inc 2017-09-01 Pres. & Chief Medical Officer
RVNC Revance Therapeutics Inc 2015-11-17 EVP and Chief Medical Officer

Arthur Peter Bertolino Latest Holdings Summary

Arthur Peter Bertolino currently owns a total of 1 stock. Arthur Peter Bertolino owns 34,001 shares of Revance Therapeutics Inc (RVNC) as of November 17, 2015, with a value of $140,424.

Latest Holdings of Arthur Peter Bertolino

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RVNC Revance Therapeutics Inc 2015-11-17 34,001 4.13 140,424

Holding Weightings of Arthur Peter Bertolino


Arthur Peter Bertolino Form 4 Trading Tracker

According to the SEC Form 4 filings, Arthur Peter Bertolino has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the sale of 7,753 shares on November 17, 2015, which brought Arthur Peter Bertolino around $303,220.

Insider Trading History of Arthur Peter Bertolino

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Arthur Peter Bertolino Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Arthur Peter Bertolino Ownership Network

Ownership Network List of Arthur Peter Bertolino

No Data

Ownership Network Relation of Arthur Peter Bertolino

Insider Network Chart

Arthur Peter Bertolino Owned Company Details

What does Innovation Pharmaceuticals Inc do?

Who are the key executives at Innovation Pharmaceuticals Inc?

Arthur Peter Bertolino is the Pres. & Chief Medical Officer of Innovation Pharmaceuticals Inc. Other key executives at Innovation Pharmaceuticals Inc include Vice President Jane A. Harness , director & 10 percent owner & Chief Financial Officer Leo Ehrlich , and director & 10 percent owner & President-Chief Scient.Officer Krishna Menon .

Innovation Pharmaceuticals Inc (IPIX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Innovation Pharmaceuticals Inc (IPIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovation Pharmaceuticals Inc (IPIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Innovation Pharmaceuticals Inc (IPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Innovation Pharmaceuticals Inc Insider Transactions

No Available Data

Arthur Peter Bertolino Mailing Address

Above is the net worth, insider trading, and ownership report for Arthur Peter Bertolino. You might contact Arthur Peter Bertolino via mailing address: C/o Innovation Pharmaceuticals Inc., 100 Cummings Center, Suite 151-b, Beverly Ma 01915.